Signaling pathways
-
F1692 Anti-IL-17c Antibody (MOR106)Summary: Anti-IL-17c Antibody (MOR106) -
F1693 Anti-GDF8/Myostatin Antibody (Apitegromab)Summary: Anti-GDF8/Myostatin Antibody (Apitegromab) -
F1694 Anti-CD14 Antibody (Atibuclimab)Summary: Anti-CD14 Antibody (Atibuclimab) -
F1696 Anti-CEACAM5/CEA/CD66e Antibody (CergutuzumAb)Summary: Anti-CEACAM5/CEA/CD66e Antibody (CergutuzumAb) -
F1697 Anti-EpCAM/TROP1/CD326 Antibody (Citatuzumab)Summary: Anti-EpCAM/TROP1/CD326 Antibody (Citatuzumab) -
F1698 Anti-TFPI Antibody (Concizumab)Summary: Anti-TFPI Antibody (Concizumab) -
F1699 Anti-Histone H1 Antibody (Derlotuximab)Summary: Anti-Histone H1 Antibody (Derlotuximab) -
F1700 Anti-GD3 Antibody (Ecromeximab)Summary: Anti-GD3 Antibody (Ecromeximab) -
F1701 Anti-GPNMB Antibody (Glembatumumab)Summary: Anti-GPNMB Antibody (Glembatumumab) -
F1702 Anti-GP6/Glycoprotein-6 Antibody (Glenzocimab)Summary: Anti-GP6/Glycoprotein-6 Antibody (Glenzocimab)